HOME >> BIOLOGY >> NEWS
ESA and EADS-CASA sign contract to build instrument for the SMOS mission

The contract, worth 62 million euros, was signed in Madrid, Spain on 11 June 2004 at the premises of the CDTI (Centre for Development of Industrial Technology). EADS-CASA now heads an industrial consortium of more than 20 companies from all over Europe, and is committed to construct the innovative MIRAS (Microwave Imaging Radiometer using Aperture Synthesis) instrument that will form the core of the SMOS mission.

Scheduled for launch in early 2007, SMOS is the second Earth Explorer Opportunity mission to be implemented as part of ESA's Living Planet Programme. The main aim of the mission is to further the development of climatological, meteorological and hydrological models by observing soil moisture over the Earth's landmasses and sea-surface salinity over the oceans for a period of at least 3 years. At the signing ceremony, Prof. Jos Achache, ESA's Director of Earth Observation Programmes, stated that, "SMOS will provide a major advancement in our ability to model and understand the global hydrological cycle."

The moisture in soil and the salt in the oceans are intrinsically linked to the Earth's water cycle and climate. Currently, in-situ measurements for soil moisture are sparse, but if we are to better understand the water cycle so that the forecasting of climate, weather and extreme events such as floods can be improved more data are urgently required. The same is true for data on ocean salinity - only a small fraction of the ocean is sampled on any regular basis. However, salinity is an important factor driving the currents in the ocean and in turn ocean circulation plays a crucial role moderating the climate. Therefore, comprehensive data on ocean salinity would greatly improve our knowledge of the conditions that influence global ocean circulation and thus climate.

Not only will this mission further our understanding of the Earth system, but it will also demonstrate a new measuring technique by adopting a completely different
'"/>

Contact: Michael Rast
michael.rast@esa.int
31-071-565-4465
European Space Agency
17-Jun-2004


Page: 1 2

Related biology news :

1. PNNL lands $10.3 million NIH biodefense contract to unlock proteomes of salmonella and pox
2. Hope Clinic of Emory Vaccine Center receives CDC contract
3. UT Southwestern researchers reveal mechanisms of smooth-muscle contraction
4. Power plants, other industry could offer contracts to farmers in helping reduce carbon emissions
5. Tufts University wins $25-million NIH contract
6. TIGR and NIAID sign $65 million microbial sequencing contract
7. HHS announces contracts to develop safer smallpox vaccines
8. Blood markers may reflect newborns potential of contracting HIV
9. Rutgers biologist wins a $1.03 million, 5 year contract to study how microbes can help clean up Superfund sites
10. Tobacco farm workers may contract tobacco sickness, Wake Forest study shows
11. Winning combination to build bone density in children

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ESA and EADS CASA sign contract build instrument for the SMOS mission

(Date:4/20/2015)... Huntington Memorial Hospital is the first facility ... miniaturized, wireless monitoring sensor to manage heart failure (HF). ... FDA-approved heart failure monitoring device that has been proven ... to manage heart failure. The CardioMEMS HF ... pulmonary artery (PA) during a non-surgical procedure to directly ...
(Date:4/14/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... York Design Awards under the category  ,Product Design – ... Awards are part of a global multi-disciplinary awards program. ... the marketplace, industry and judging panel. Winners will be ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... April 23, 2015, after the close of market. The ... and investors at 2:00 p.m. PT (5:00 p.m. ET), ... To participate on the live call, analysts and ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2
(Date:4/28/2015)... April 28, 2015  US-Australian drug discovery company, Novogen ... it received a letter from NASDAQ informing it that ... 5550(b) (Listing Rule). In November 2014, ... the Company to submit a plan to regain compliance ... minimum of $2,500,000 in stockholders, equity as of June ...
(Date:4/28/2015)... 28, 2015 IMS is releasing ... it to the web and provide greater accessibility ... friendly reporting metrics increase data warehouse’s utility; plus, ... recall and access “on-the-go” makes data analysis even ... client feedback to assist in repository analytics and ...
(Date:4/28/2015)... 2015 Spartan Bioscience today announced that ... selected by the Ottawa Chamber of Commerce as one ... was selected from over 240 applicants based on his ... to Spartan, Dr. Lem founded Plexagen Diagnostics, and also ... holds a Medical Degree from the University of Ottawa, ...
(Date:4/27/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... year ended December 31, 2014. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... provide the outcome management and investors had hoped ... Therapeutics", said Andrew Rae , President & ...
Breaking Biology Technology:Novogen Regains Full Compliance with NASDAQ Listing Rule 2Novogen Regains Full Compliance with NASDAQ Listing Rule 3Spartan Bioscience Announces Paul Lem Named Ottawa’s Top 40 Under 40 2iCo Therapeutics Announces Year End 2014 Financial Results 2iCo Therapeutics Announces Year End 2014 Financial Results 3iCo Therapeutics Announces Year End 2014 Financial Results 4
Cached News: